ClinicalTrials.Veeva

Menu

Endovascular Treatment of Primary Common FEmoral Artery atheroSclerotic Disease wiTh IntraVAscular Litothripsy (FESTIVAL)

U

University of Pisa

Status

Enrolling

Conditions

Critical Limb-Threatening Ischemia
Common Femoral Artery Occlusion
Common Femoral Artery Stenosis
Peripheral Arterial Disease

Treatments

Device: Intravascular litothripsy (IVL)

Study type

Observational

Funder types

Other

Identifiers

NCT05821829
FESTIVAL

Details and patient eligibility

About

Prospective, nonrandomized, multicenter, national, multidisciplinary, real-world data collection with the aim to evaluate the short-term safety and efficacy of intravascular lithotripsy in the treatment of steno-obstructive disease of the common femoral artery

Enrollment

150 estimated patients

Sex

All

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients with peripheral arterial disease (Rutherford class 3-6)
  2. Presence of a steno-obstructive lesion of the common femoral artery (Azema classification 1-3)
  3. Possible endovascular treatment of both the iliac axis and/or femoro-distal vessels
  4. Possible post-dilatation with plain or drug-coated balloon angioplasty

Exclusion criteria

  1. Concomitant open surgery (ilio-femoral or femoro-distal bypass)
  2. Presence of a steno-obstructive lesion of the common femoral artery in previous open surgery (Azema classification 4)
  3. Presence of a steno-obstructive lesion of the common femoral artery after a previous endovascular procedure

Trial contacts and locations

1

Loading...

Central trial contact

Nicola Troisi, Prof

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems